Mereo BioPharma Group (MREO) Insider Trading & Ownership $2.86 -0.02 (-0.52%) Closing price 03:59 PM EasternExtended Trading$2.86 0.00 (0.00%) As of 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Mereo BioPharma Group (NASDAQ:MREO) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage4.13%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)6Amount OfInsider Selling(Last 12 Months)$1.28 M Get MREO Insider Trade Alerts Want to know when executives and insiders are buying or selling Mereo BioPharma Group stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address MREO Insider Buying and Selling by Quarter Mereo BioPharma Group Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails9/12/2024Charles SermonGeneral CounselSell9,980$4.47$44,610.60 9/12/2024Christine Ann FoxCFOSell9,128$4.47$40,802.16 9/12/2024Denise Scots-KnightCEOSell28,611$4.47$127,891.17 9/12/2024John A LewickiInsiderSell5,212$4.47$23,297.64 8/22/2024Deepika PakianathanDirectorSell105,244$4.43$466,230.92 6/25/2024Charles SermonGeneral CounselSell14,202$3.69$52,405.38 6/25/2024Christine Ann FoxCFOSell12,990$3.69$47,933.10 6/25/2024Denise Scots-KnightCEOSell40,712$3.69$150,227.28 6/25/2024John A LewickiInsiderSell7,416$3.69$27,365.04 5/22/2024Alexandra Hughes-WilsonInsiderSell100,432$2.97$298,283.04 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. (Data available from 1/1/2013 forward) MREO Insider Trading Activity - Frequently Asked Questions Who is on Mereo BioPharma Group's Insider Roster? The list of insiders at Mereo BioPharma Group includes Alexandra Hughes-Wilson, Charles Sermon, Christine Ann Fox, Deepika Pakianathan, Denise Scots-Knight, and John A Lewicki. Learn more on insiders at MREO. What percentage of Mereo BioPharma Group stock is owned by insiders? 4.13% of Mereo BioPharma Group stock is owned by insiders. Learn more on MREO's insider holdings. Which Mereo BioPharma Group insiders have been selling company stock? The following insiders have sold MREO shares in the last 24 months: Alexandra Hughes-Wilson ($298,283.04), Charles Sermon ($97,015.98), Christine Ann Fox ($88,735.26), Deepika Pakianathan ($466,230.92), Denise Scots-Knight ($278,118.45), and John A Lewicki ($50,662.68). How much insider selling is happening at Mereo BioPharma Group? Insiders have sold a total of 333,927 Mereo BioPharma Group shares in the last 24 months for a total of $1,279,046.33 sold. Mereo BioPharma Group Key ExecutivesDr. Denise Vera Scots-Knight Ph.D. (Age 65)Co-Founder, CEO & Executive Director Compensation: $890.56kMr. Charles Edward Sermon (Age 55)Co-Founder, General Counsel, Business Development & Company Secretary Compensation: $625.79kMs. Christine Fox CPA (Age 43)Chief Financial Officer Compensation: $569.77kDr. John P. Richard M.B.A. (Age 67)Co-Founder & Chief Business Officer Dr. John A. Lewicki Ph.D. (Age 72)Chief Scientific Officer Dr. Jackie Parkin (Age 66)Senior VP & Therapeutic Head Ms. Alexandra Hughes-Wilson (Age 53)Chief of Patient Access & Commercial Planning Dr. Suba Krishnan (Age 59)Senior Vice President of Clinical Development Mr. Bo KaraSenior VP and Head of Pharmaceutical Development & CMC More Insider Trading Tools from MarketBeat Related Companies Vera Therapeutics Insider Ownership Iovance Biotherapeutics Insider Ownership Praxis Precision Medicines Insider Ownership Wave Life Sciences Insider Ownership Apogee Therapeutics Insider Ownership Disc Medicine Insider Ownership Arcutis Biotherapeutics Insider Ownership Amphastar Pharmaceuticals Insider Ownership Immunocore Insider Ownership Kiniksa Pharmaceuticals Insider Ownership Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 3 Stocks With Robust Growth Outlooks Insiders Are BuyingMETA Stock: Insider Selling Ramps Up—What It Means for InvestorsThese Are the Dividend Stocks Insiders Bought in JanuaryInsider Selling in Tech Stocks Spikes in Q43 Small-Cap Stocks Insiders and Institutions Are Buying This page (NASDAQ:MREO) was last updated on 2/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon “obliterates” Bill Gates?All 10 of the world's biggest money managers follow my work, and the Pentagon, the FBI and Harvard professors ...Altimetry | SponsoredNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | Sponsored My 2025 AI BlueprintI first recommended Bitcoin at $300 in 2013 … before it went up 33,645%. Now, I am revealing my 2025 AI Blu...Weiss Ratings | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredAmerica cannot power AIThere’s a fatal flaw at the heart of the AI revolution… With AI continuing to explode in popularity, tech c...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mereo BioPharma Group plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Mereo BioPharma Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MREO Stock Alerts